Key result
Inhibitors of signaling enzymes that prevented ATP release prevented or delayed the generation of PAR-1 and PAR-4 amino-terminal peptides in response to alpha-thrombin, SFLLRN, or AYPGKF.
ATP-dependent phosphorylation reactions catalyzed by PKC help generate a platelet-derived proteinase that propagates human platelet PAR-1 and -4 activation.
Supports PKC-ATP axis in platelet PAR propagation; hypothesis-generating from animal data and should not yet change practice.
Activation of washed human platelets initiated with alpha-thrombin, SFLLRN, or AYPGKF invariably results in the generation of PAR-1-(1-41) and PAR-4-(1-47). PAR-1-(1-41) and PAR-4-(1-47) are amino-terminal peptides generated when PAR-1 and -4 are cleaved in their first extracellular domains after R(41) and R(47), respectively, to expose the tethered ligand domains of PAR-1 and -4. Since soybean trypsin inhibitor decreases generation of PAR-1-(1-41) and PAR-4-(1-47) and other platelet aggregation-related responses to these three agonists, but does not inactivate alpha-thrombin, a platelet trypsin-like proteinase apparently activates PAR-1 and -4 to propagate PAR-dependent platelet responses. This study identified the signaling pathways implicated in the generation of the platelet proteinase that in turn produces PAR-1-(1-41) and PAR-4-(1-47), to thereby drive the subsequent PAR-dependent platelet aggregation-related responses to alpha-thrombin, SFLLRN, or AYPGKF. Only inhibitors of signaling enzymes that prevented ATP release (forskolin, PGE(1), or BIMI-1) prevented or delayed the generation of PAR-1-(1-41) and PAR-4-(1-47) in response to all three agonists. SBTI prevented platelet aggregation initiated by alpha-thrombin, SFLLRN, or AYPGKF but did so less effectively when it was added 10 s after each agonist. Thus, the platelet-derived proteinase acts within 10 s of each agonist addition to generate PAR-1-(1-41) and PAR-4-(1-47). Furthermore, alpha-thrombin may not effectively catalyze PAR-1-(1-41) and PAR-4-(1-47) generation. We propose that unidentified ATP-dependent phosphorylation reactions catalyzed by PKC help to generate the platelet-derived proteinase that propagates human platelet PAR-1 and -4 activation by the three agonists.
No takes yet. Share an insight, caveat, or question.
Ofosu et al. (2009) studied Platelet activation. alpha-thrombin, SFLLRN, or AYPGKF vs. Signaling enzyme inhibitors (forskolin, PGE1, BIMI-1, SBTI) was evaluated on Generation of PAR-1-(1-41) and PAR-4-(1-47) and platelet aggregation. Inhibitors of signaling enzymes that prevented ATP release prevented or delayed the generation of PAR-1 and PAR-4 amino-terminal peptides in response to alpha-thrombin, SFLLRN, or AYPGKF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: